Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health SystemsJOURNAL OF GENERAL INTERNAL MEDICINEIF4.22023-11-063PRE
The association between buprenorphine treatment duration and mortality: a multi-site cohort study of people who discontinued treatmentADDICTIONIF5.32022-07-238OA
Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With Sustained Virological Response to Interferon-Free Direct-Acting Antiviral Therapy (2014-2018)CLINICAL INFECTIOUS DISEASESIF7.32022-02-112PRE
Incidence of Malignancies Among Patients With Chronic Hepatitis B in US Health Care Organizations, 2006-2018JOURNAL OF INFECTIOUS DISEASESIF4.52022-01-178PRE
Predicting adolescent alcohol and other drug problems using electronic health records dataJOURNAL OF SUBSTANCE ABUSE TREATMENTIF42022-01-010PREAI
The Persistence of Underreporting of Hepatitis C as an Underlying or Contributing Cause of Death, 2011-2017CLINICAL INFECTIOUS DISEASESIF7.32021-02-093OAAI
Sex Differences in Extrahepatic Outcomes After Antiviral Treatment for Hepatitis CAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62020-12-244PRE
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of CureHEPATOLOGY COMMUNICATIONSIF4.62020-11-2918OAAI
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitisclinical epidemiologyIF3.22020-11-015OAAI
Mental health status in veterans residing in rural versus non-rural areas: results from the veterans' health studyMILITARY MEDICAL RESEARCHIF22.92020-09-2113OAAI
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary CholangitisAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62020-01-2717PREAI
Guard/Reserve service members and mental health outcomes following deployment: Results from the Veterans' Health StudyGENERAL HOSPITAL PSYCHIATRYIF3.72020-01-013PREAI
Trends in Diagnosed Chronic Hepatitis B in a US Health System Population, 2006-2015OPEN FORUM INFECTIOUS DISEASESIF3.82019-06-145OAAI
Complications of chronic hepatitis B: Prevalence and disparities in a US health system cohort 2006-2016JOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Inadequate response to UDCA among PBC patients under routine care in the US: Rising serum bilirubin even in the normal range is a risk factor and subsequent clinical follow-up differs based on treatment responseJOURNAL OF HEPATOLOGYIF332019-04-010PREAI
Effect of treatment of hepatitis B patients with tenofovir disoproxil or entecavir on risk of hepatocellular cancer death in a US CohortJOURNAL OF HEPATOLOGYIF332019-04-0112PREAI
Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis CLIVER INTERNATIONALIF5.22019-01-2419OAAI
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetesALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72019-01-1641OAAI
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health SystemsCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122018-08-0149PREAI
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With TreatmentCLINICAL GASTROENTEROLOGY AND HEPATOLOGYIF122018-08-0177OAAI